Dr Joern-peter Halle
Peter is leading the Translational Innovation Platform Immuno-Oncology function in Merck Biopharma. Most recently, he was Head of the President’s Office and of Strategy and Business operations in Merck Healthcare. Prior to this, he was responsible for the program leaders of the oncology portfolio, part of the cross-functional oncology leadership team, and Head of Early Stage Licensing of Merck Serono. He started his carrier in Merck 10 years ago as a member of the corporate development team and was member of the Serono acquisition and integration team. Prior to joining Merck, he co-founded a biotech company focusing on R&D in dermatology where he served as a Chief Business Officer. Peter holds a PhD in molecular biology from the University of Konstanz and began his carrier as a postdoc in biochemistry at the Gene Center Munich.
R&D in dermatology